AIM ImmunoTech Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2024 | 2 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
AIM ImmunoTech Inc. Earnings Date And Information
AIM ImmunoTech Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.04. The company had revenue of 35,000 for the quarter and had revenue of 202,000 for the year. AIM ImmunoTech Inc. has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -0.51. AIM ImmunoTech Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
AIM ImmunoTech Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.10 | -$0.06 | 0.04 | $17,500 | $35,000 |
| 08/14/2024 | Q2 2024 | -$0.12 | -$0.03 | 0.09 | $17,500 | $50,000 |
| 05/15/2024 | Q1 2024 | -$0.12 | $40,000 | |||
| 03/29/2024 | Q4 2023 | -$0.26 | $65,000 | |||
| 11/14/2023 | Q3 2023 | -$0.11 | -$0.16 | -0.05 | $24,000 | $46,000 |
| 08/14/2023 | Q2 2023 | -$0.10 | $23,000 | $42,000 | ||
| 05/12/2023 | Q1 2023 | -$0.06 | $49,000 | |||
| 03/31/2023 | Q4 2022 | -$0.09 | $56,000 | |||
| 11/14/2022 | Q3 2022 | -$0.13 | $210,000 | $21,000 | ||
| 08/15/2022 | Q2 2022 | -$0.07 | -$0.10 | -0.03 | $137,667 | $30,000 |
| 05/13/2022 | Q1 2022 | -$0.09 | $33,000 | |||
| 03/31/2022 | Q4 2021 | -$0.08 | -$0.12 | -0.04 | $50,000 | |
| 11/15/2021 | Q3 2021 | -$0.08 | $38,333 | $33,000 | ||
| 08/16/2021 | Q2 2021 | -$0.12 | $349,333 | $23,000 | ||
| 05/17/2021 | Q1 2021 | -$0.08 | $28,000 | |||
| 03/30/2021 | Q4 2020 | -$0.07 | -$0.09 | -0.02 | $42,000 | |
| 11/12/2020 | Q3 2020 | -$0.09 | $360,000 | $36,000 | ||
| 08/14/2020 | Q2 2020 | -$0.10 | -$0.11 | -0.01 | $51,000 | $40,000 |
| 05/13/2020 | Q1 2020 | -$0.22 | $45,000 | |||
| 03/30/2020 | Q4 2019 | -$0.37 | -$0.07 | 0.3 | $50,000 |
AIM ImmunoTech Inc. Earnings: Frequently Asked Questions
-
When is AIM ImmunoTech Inc.'s earnings date?
AIM ImmunoTech Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based off last year's report dates.
-
Did AIM ImmunoTech Inc. beat their earnings estimates last quarter?
In the previous quarter, AIM ImmunoTech Inc. (:AIM) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.04.
-
How can I listen to AIM ImmunoTech Inc.'s earnings conference call?
The conference call for AIM ImmunoTech Inc.'s latest earnings report can be listened to online.
-
How can I read AIM ImmunoTech Inc.'s conference call transcript?
The conference call transcript for AIM ImmunoTech Inc.'s latest earnings report can be read online.
-
How much revenue does AIM ImmunoTech Inc. generate each year?
AIM ImmunoTech Inc. (:AIM) has a recorded annual revenue of $202,000.
-
How much profit does AIM ImmunoTech Inc. generate each year?
AIM ImmunoTech Inc. (:AIM) has a recorded net income of $202,000. AIM ImmunoTech Inc. has generated $-0.6 earnings per share over the last four quarters.
-
What is AIM ImmunoTech Inc.'s price-to-earnings ratio?
AIM ImmunoTech Inc. (:AIM) has a price-to-earnings ratio of -0.51 and price/earnings-to-growth ratio is -0.03.
